SANAI HEALTH INDUSTRY GROUP COMPANY LIMITED

Sanai Health Industry Group Company Limited

1889

KYG7785S1075

Pharmaceuticals

Market Closed - Hong Kong S.E. Other stock markets 04:08:20 2024-04-26 am EDT			5-day change	1st Jan Change
0.026 ^HKD	-10.34%		-7.14%	-59.38%

Apr. 18	Sanai Health Unit to Offload 59% Stake in Genetic Testing Provider	MT
Apr. 17	Zhou Chen agreed to acquire 59% stake in Zentrogene Bioscience Laboratory Limited from Sanai Health Industry Group Company Limited for HKD 22 million.	CI

Sanai Health Industry : EXCHANGE NOTICE - RESUMPTION OF TRADING

September 07, 2021 at 08:52 pm EDT

Listed Company Information

EXCHANGE NOTICE - RESUMPTION OF TRADING
Trading in the shares (stock code: 01889) of Sanai Health Industry Group Company Limited will be resumed at 9:00 a.m. today (8/9/2021).

Attachments

Original document
Permalink

Disclaimer

Wuyi International Pharmaceutical Co. Ltd. published this content on 08 September 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 08 September 2021 00:51:01 UTC.

Latest news about Sanai Health Industry Group Company Limited

Sanai Health Unit to Offload 59% Stake in Genetic Testing Provider	Apr. 18	MT
Zhou Chen agreed to acquire 59% stake in Zentrogene Bioscience Laboratory Limited from Sanai Health Industry Group Company Limited for HKD 22 million.	Apr. 16	CI
Sanai Health Industry Group Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 27	CI
Sanai Health Industry Anticipates 40% Profit Decline in 2023	Mar. 26	MT
Sanai Health Industry Group Company Limited Provides Group Earnings Guidance for the Year Ended December 31, 2023	Mar. 25	CI
Sanai Health Industry Group's Unit to Acquire Majority Stake in Technology Company	Mar. 05	MT
Court Orders Retrial of Sanai's Dispute With Beijing Cultural Technology	Dec. 20	MT
Sanai Health Industry Group Company Limited Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-29	CI
Sanai Health Signs MOU for Potential Acquisition of 51% Interest in Greensky Biological	23-05-09	MT
Sanai Health Industry Group Company Limited entered into a memorandum of understanding to acquire a 51% stake in Hangzhou Greensky Biological Technology Company Limited from certain shareholders.	23-05-08	CI
Sanai Health Industry Group Company Limited Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-30	CI
Sanai Health Industry to Boost 2022 Profit by 224%	23-03-29	MT
Sanai Health Industry Group Company Limited Provides Earnings Guidance for the Year Ended 31 December 2022	23-03-28	CI
Sanai Health Industry's Convertible Bonds Mature; Shares Slip 4%	23-02-10	MT
Sanai Health Industry's H1 Profit Rises as Revenue Doubles	22-09-01	MT
Sanai Health Industry Group Company Limited Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-31	CI
Sanai Health Industry Group Company Limited Provides Earnings Guidance for the Six Months Ended 30 June 2022	22-08-26	CI
Sanai Health Chairman Resigns; Shares Gain 4%	22-06-20	MT
Sanai Health Industry Group Company Limited Announces Executive Changes	22-06-17	CI
Sanai Health Industry Group Company Limited Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-29	CI
Sanai Health Industry Group Company Limited Provides Earnings Guidance for the Year Ended 31 December 2021	22-03-27	CI
Sanai Health Sells $9 Million of Convertible Bonds	22-02-10	MT
Sanai Health Industry Group Company Limited announced that it has received HKD 72 million in funding	22-02-08	CI
Sanai Health Industry Extends Deadline to Conclude Sale of $9 Million Convertible Bonds	22-01-31	MT
Sanai Health Industry Raising $9 Million to Lift Working Capital	22-01-13	MT

Chart Sanai Health Industry Group Company Limited

Duration

Period

Chart Sanai Health Industry Group Company Limited

More charts

Company Profile

Sanai Health Industry Group Company Limited is an investment holding company principally engaged in the general trading business and pharmaceutical products business. The Company operates its business through three segments. The Pharmaceutical Products segment mainly engages in the development, manufacturing, marketing and sales of pharmaceutical products, sales of pharmaceutical related software and provision of consultancy services. The Finance Leasing segment mainly engages in the provision of finance leasing services. The Other General Trading segment engages in the distribution of fitness equipment, electric appliances and other goods for general trading.

Sector

Pharmaceuticals

Calendar

2024-08-26 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
SANAI HEALTH INDUSTRY GROUP COMPANY LIMITED	-59.38%	12.7M
ELI LILLY AND COMPANY	+25.83%	661B
NOVO NORDISK A/S	+27.00%	566B
JOHNSON & JOHNSON	-6.76%	352B
MERCK & CO., INC.	+20.34%	332B
ABBVIE INC.	+3.00%	283B
ASTRAZENECA PLC	+13.09%	231B
NOVARTIS AG	+5.46%	200B
ROCHE HOLDING AG	-9.61%	195B
AMGEN INC.	-6.26%	145B